Table of Contents Table of Contents
Previous Page  18 / 114 Next Page
Information
Show Menu
Previous Page 18 / 114 Next Page
Page Background

18 The US-Israel Legal Review 2019

ISRAEL DESKS LEAGUE TABLES

investment management firms, the firm also acts

as a listing agent on the Irish Stock Exchange and

the Cayman Islands Stock Exchange.

It is in the capital markets arena, where the

team’s Israel-related work has particularly shone

during the past year. London-based Matthew

Gilbert, head of the firm’s BVI group, guides a team

of seven lawyers, which is prominent in debt capital

markets and has advised on significant bond

offerings in Israel. The team represented global

investment firm, Starwood Capital Group, which

has USD 60 billion of assets under management, on

a USD 264 million debt offering to Israeli investors

in order to refinance loans on ageing US shopping

malls. The teamalso advised Silverstein Properties,

the longstanding New York-based property

developer, landlord and management firm, on its

USD

200 million b

ond offering on the Tel Aviv Stock

Exch

ange – its firs

t on the Israeli market.

Visit

:

maples.com

MC

DERMOTT W

ILL EMERY

Backed by the multidisciplinary resources of

the firm’s 20 offices, McDermott Will & Emery

(“McDermott”)isknownforextensivetransactional

advice, particularly capital markets transactions,

involving Israeli clients across many cutting-edge

sectors, especially technology, bio-tech and life

science. McDermott takes pole position in the Israel

Desks Capital Markets category.

With considerable experience in advising these

types of companies, partners Gary Emmanuel

and Mark Selinger in the firm’s New York office

are key figures in the 18-strong team, which has

recently provided strategic advice regarding

acquisitions, IPOs, direct and follow-on offerings

for a number of Israeli clients, such as Ability

Inc., provider of cyber intelligence tools used by

security and intelligence agencies, military forces,

law enforcement and homeland security agencies

worldwide, and clinical-stage biopharmaceutical

company Galmed. The team also represents some

of the most prominent US underwriters, such as

H.C. Wainwright & Co., one of the oldest financial

institutions and one of the leading placement

agents in the country, as underwriter in a number

of pu

blic and follow-o

n offerings for Israeli medical

devic

e companies, Ins

pireMD, Inc. andMedigus Ltd.

Visit

:

www.mwe.com

MORRISON & FOERSTER

Morrison & Foerster is one of the longest standing

players with regards to the development of the

Israeli market, acting for many Israeli companies in

their dealingswithEurope, Asia and elsewhere.With

a comprehensive practice, for more than 40 years,

the team has supported clients with regards to

their cross-border M&A transactions, securities and

capital markets transactions, for example, advising

Mobileye on its USD 890 million IPO, the largest US

IPO ever by an Israeli company back in 2014.

The Israel Desk enjoys a strong reputation

acting for US and Asia-based investors in venture

capital investments in, and acquisitions of, private

Israeli companies, in a variety of sectors, notably

bio-tech, software, artificial intelligence (“AI”),

and medical sectors. Recently, the team advised

Japan’s SoftBank Group on two key transactions –

its USD 120 million funding of Israeli-led insurance

start-up, Lemonade Insurance as it looks to expand

outsi

de the US, and on a USD 35 million financ

ing

of Isr

aeli sports AI platform, Heed Technology L

td.

Visit

:

www.mofo.com/practices/international/

israe

l/

PEARL COHEN ZEDEK LATZER BARATZ (USA)

Pearl Cohen’s ranking as one of the top law firms in

intellectual property is once again underlined by its

involvement in a whole host of instructions in the

patent field. The firm’s teams in New York, Boston,

Los Angeles and London comprise experienced

patent attorneys, patent agents, scientific advisors

and transactional lawyers, who have been advising

on technologies spanning the gamut of high-tech,

medical, biologic and chemical technologies.

The New York office leads the firm’s US

intellectual property and technology-related work

in prosecution (patents and trademarks), patent

and other IP litigation, and technology transactional

work. Managing Partner, Zeev Pearl, and Life

Scien

ces Chair, Mark Cohen are key co

ntacts in the

New

York office.

Visit

:

www.pearlcohen.com/about-us/

SCH

ULMAN & CHARISH

US boutique law firm Schulman & Charish

specializesinrepresentingIsraeliandUScompanies

and individuals as lead counsel in complex business

litigation, international arbitration, and defense